A qualitative study exploring the impact and consequence of the medicines use review service on pharmacy support-staff

Main Article Content

Asam Latif
Helen Boardman
Kristian Pollock


Pharmacists' Aides, Pharmacists, Workflow, Community Pharmacy Services, Drug Utilization Review, Professional Practice, United Kingdom


Background: Pharmacy support-staff (pharmacy technicians, dispensers and Medicines Counter Assistants) support the delivery of pharmaceutical and retail functions of the pharmacy. Workflow is supervised and at times dependent upon the pharmacist’s presence. Policy makers and pharmacy’s representative bodies are seeking to extend the community pharmacist's role including requiring the pharmacist to undertake private consultations away from the dispensary and shop floor areas. However, support-staff voices are seldom heard and little is known about the impact such policies have on them.

Objective: The objective of this study is to explore the impact and consequences of the English Medicine Use Review (MUR) service on pharmacy support-staff. 

Method: Ten weeks of ethnographic-oriented observations in two English community pharmacies and interviews with 5 pharmacists and 12 support-staff. A thematic approach was used to analyse the data.

Results: Despite viewing MURs as a worthwhile activity, interviews with support-staff revealed that some felt frustrated when they were left to explain to patients why the pharmacist was not available when carrying out an MUR. Dependency on the pharmacist to complete professional and accuracy checks on prescriptions grieved dispensing staff because dispensing workflow was disrupted and they could not get their work done. Medicines Counter Assistants were observed to have less dependency when selling medicines but some still reported concerns over of customers and patients waiting for the pharmacist. A range of tacit and ad hoc strategies was consequently found to be deployed to handle situations when the pharmacist was absent performing an MUR. 

Conclusions: Consideration should be given to support-staff and pharmacists’ existing work obligations when developing new pharmacy extended roles that require private consultations with patients. Understanding organisational culture and providing adequate resourcing for new services are needed to avoid improvisations or enactments by pharmacy support-staff and to allow successful innovation and policy implementation.

Abstract 3007 | PDF Downloads 938


1. Royal Pharmaceutical Society of Great Britain. Pharmacy support staff roles and definitions (updated May, 2009); 2009. http://www.docstoc.com/docs/27981460/Pharmacy-support-staff-roles-and-definitions (Accessed 13 Mar 2013).

2. Ylänne V, John DN. Roles of medicines counter assistants in advice giving in community pharmacies: a Discourse Analysis. Pharm World Sci. 2008;30(2):199-207.

3. Banks J, Shaw A, Weiss MC. The community pharmacy and discursive complexity: a qualitative study of interaction between counter assistants and customers. Health Soc Care Community. 2007;15(4):313-321.

4. Mullen R. Skill mix in community pharmacy: exploring and defining the roles of dispensary support staff. London: Royal Pharmaceutical Society of Great Britain; 2004.

5. Lea VM, Corlett SA, Rodgers RM. Workload and its impact on community pharmacists' job satisfaction and stress: a review of the literature. Int J Pharm Pract. 2012;20(4):259-271. doi: 10.1111/j.2042-7174.2012.00192.x.

6. Rutter PM. Pharmacist work patterns: are they affected by staffing levels and prescription numbers? Int J Pharm Pract. 2002;10(suppl):R49.

7. Savage I. Time for customer contact in pharmacies with and without a dispensing technician. Int J Pharm Prac. 1995;3(4):193-199.

8. Royal Pharmaceutical Society. Medicines, Ethics and Practice: The professional guide for pharmacists. Edition 36. London: Royal Pharmaceutical Society; 2012.

9. Bell HM, McElnay JC, Hughes CM. A self-reported work sampling study in community pharmacy practice. Pharm World Sci. 1999;21(5):210-216.

10. McCann L, Hughes CM, Adair CG. A self-reported work-sampling study in community pharmacy practice: a 2009 update. Pharm World Sci. 2010;32(4):536-543. doi: 10.1007/s11096-010-9405-x.

11. Edmund J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practitioners in the United Kingdom. Soc Sci Med. 2001;53(7):943-955.

12. Noyce, PR. Providing patient care through community pharmacies in the UK: Policy, practice, and research. Ann Pharmacother. 2007;41(5):861-868.

13. Commonwealth Department of Health and Aged Care. Domiciliary Medication Management—Home Medicines Review. Helping your patients manage their medicines at home. Canberra: Commonwealth Department of Health and Aged Care, 2001. http://pivotwest.org.au.titan.imagin8.com/icms_docs/12623_What_is_DMMR_.pdf (Accessed 13 Mar 2013).

14. Dolovich L, Gugnon A, McAiney CA, Sparrow L, Burns S. Initial pharmacist experience with the Ontario-based MedsCheck program. Can Pharm J. 2008;141(6):339-345. doi: 10.3821/1913-701X-141.6.339.

15. Lee E, Braund R, Tordoff J. Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008. N Z Med J. 2009;122(1293):3566.

16. Department of Health. The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions. London: Department of Health; 2005.

17. Blenkinsopp A, Bond C, Celino G, Inch J, Gray N. National Evaluation of the New Community Pharmacy Contract. London: Pharmacy Practice Research Trust, 2007. http://www.pprt.org/Documents/ResearchFunding/National_evaluation_of_the_new_community_pharamcy_contract.pdf (Accessed 17 Mar 2013).

18. Royal Pharmaceutical Society of Great Britain (2005) Law and Ethics Bulletin. Interim Guidance for pharmacist supervision and private consultation areas. http://faculty.ksu.edu.sa/hisham/Documents/RPSGB_Files_/7/LEBphsupconsultareas.pdf (Accessed 13 Mar 2013).

19. Silverman D. Interpreting Qualitative Data – methods for analysing talk, text and interaction. Thousand Oaks: CA: Sage Publication; 1993.

20. Ziebland S, McPherson A. Making sense of qualitative data analysis: an introduction with illustrations from DIPEx (personal experiences of health and illness). Med Educ. 2006;40(5):405-414.

21. Charmaz K. Constructing grounded theory. A practical guide through qualitative analysis. Thousands Oaks: Sage; 2006.

22. Latif A, Pollock K, Boardman H. The contribution of the Medicines Use Review (MUR) consultation to counseling practice in community pharmacies. Patient Educ Couns. 2011;83(3):336-344. doi: 10.1016/j.pec.2011.05.007.

23. Bradley F, Elvey R, Ashcroft DM, Hassell K, Kendall J, Sibbald B, Noyce P. The challenge of integrating community pharmacists into the primary health care team: A case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration. J Interprof Care. 2008;22(4):387-398. doi: 10.1080/13561820802137005.

24. Eades EC, Ferguson JS, O'Carroll RE. Public health in community pharmacy: A systematic review of pharmacist and consumer views. BMC Public Health. 2011;11:582. doi: 10.1186/1471-2458-11-582.

25. Lounsbery JL, Green CG, Bennett MS, Pedersen CA.Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. J Am Pharm Assoc (2003). 2009;49(1):51-58. doi: 10.1331/JAPhA.2009.017158.

26. Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract. 2010;8(1):35-42.

27. Roberts AS, Benrimoj SI, Chen TF, Williams K, Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Prac. 2006:14(3):163-170.

28. McDonald R, Cheraghi-Sohi S. Sanders, C, Ashcroft D. Professional status in a changing world: The case of Medicines Use Reviews in English community pharmacy. Soc Sci Med. 2010;71(3):451-458. doi: 10.1016/j.socscimed.2010.04.021.

29. Urban R, Rivers P, Morgan J. Perceptions of medicines use reviews – the views of community pharmacists within a West Yorkshire primary care trust. Pharm J. 2008;281(7519):303-305.

30. Bradley F, Wagner AC, Elvey R, Noyce PR, Ashcroft DM. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: A multi-method study. Health Policy. 2008;88(2-3):258-268. doi: 10.1016/j.healthpol.2008.03.013.

31. Harding G, Wilcock M. Community pharmacists' perceptions of medicines use reviews and quality assurance by peer review. Pharm World Sci. 2010;32(3):381-385. doi: 10.1007/s11096-010-9381-1.

32. Wilcock M, Harding G. What do pharmacists think of MURs and do they change prescribed medication? Pharm J. 2008;281(7514):163-167.

33. Braund R, Chesney KM, Keast EP, Ng LJ, Qi S, Samaranayaka S, Wang E. Are all pharmacy staff interested in potential future roles? Int J Pharm Pract. 2012;20(6):417-421. doi: 10.1111/j.2042-7174.2012.00216.x.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>